| JVMSX | VVMCX | JVMSX / VVMCX | |
| Total Expense Ratio | 1.24 | 0.83 | 149% |
| Annual Report Gross Expense Ratio | 1.25 | 0.83 | 151% |
| Fund Existence | 14 years | 28 years | - |
| Gain YTD | 13.988 | 1.890 | 740% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 23.6B | 701M | 3,367% |
| Annual Yield % from dividends | 0.34 | 1.07 | 32% |
| Returns for 1 year | 8.28 | 5.72 | 145% |
| Returns for 3 years | 17.35 | 1.29 | 1,345% |
| Returns for 5 years | 13.82 | -14.60 | -95% |
| Returns for 10 years | 57.71 | -3.81 | -1,514% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CLWFX | 85.06 | 0.68 | +0.81% |
| Columbia Cornerstone Growth Inst 2 | |||
| PCLCX | 15.90 | 0.08 | +0.51% |
| PACE Large Co Growth Equity P | |||
| WCMSX | 25.38 | 0.04 | +0.16% |
| WCM International Small Cap Growth Instl | |||
| DIFFX | 12.90 | -0.03 | -0.23% |
| MFS Diversified Income R3 | |||
| SHPCX | 14.93 | -0.17 | -1.13% |
| Saratoga Health & Biotechnology C | |||